International News
Verizon launches 5G tech in over 30 cities
Verizon has launched its 5G technology in over 30 cities and 15 NFL stadiums in the US on Monday, reaching its goal before its deadline for an initial roll-out by the end of 2019.
US new home sales slightly below forecasts in November
Figures for new home sales in the US came in a tad below forecasts in November.
US durable goods orders slump in November amid declines for defence
Orders in the US for goods made to last more than three years surprised sharply to the downside last month, amid a big drop in demand for military aircraft.
US open: Stocks record early gains as record-setting rally continues
Wall Street stocks recorded some early gains on Monday ahead of the Christmas break in trading later in the week.
Boeing CEO resigns after 737 Max fiasco
Boeing chief executive officer Dennis Muilenburg resigned on Monday as the manufacturer struggles to get back on track following two fatal crashes involving its 737 Max jets and heightened criticism of the company's failure to prioritise its engineering and safety.
Asia report: China markets fall despite positive trade news
Markets in Asia closed flat to lower on Monday, as stocks in China tumbled even after weekend developments that boosted optimism on the trade front.
China expands list of products with reduced tariffs
Economic authorities in China unveiled tariff cuts at the start of the week in a bid to bolster domestic demand and further open up its economy.
Emails show Trump blocked aid to Ukraine after phone call with Zelenskiy
Newly-released government emails show Pentagon officials froze military aid for Ukraine 90 minutes after a controversial phone call last July between the US President, Donald Trump, and his Ukrainian counterpart, Volodymyr Zelenskiy.
US pre-open: Futures have stocks continuing historic rally
US futures had stocks opening slightly higher on Monday ahead of the Christmas break in trading later in the week.
Sarepta Therapeutics flies after partnering with Roche on DMD gene therapy
Switzerland's Roche has bought the rights to launch and sell one of Sarepta Therapeutics's gene therapy treatments for Duchenne muscular dystrophy outside of the States, sending shares in the US-based biotechnology outfit flying in premarket trading.